Abstract
Willingness to pay (WTP) has been used in Sweden to evaluate the value of antihypertensive therapy. The Swedish studies indicate that hypertensive patients are willing to pay between $107 and $120 per month for their therapy. We conducted a similar study in a population of hypertensive patients in a large, staff-model, managed care organization (Group Health Cooperative of Puget Sound). Participants returned a postal survey containing a WTP question with 10 "bids" ranging from $25 to $250. Respondents recorded whether they would accept or reject each bid at the stated dollar value. Demographic information such as age, income, and perceived health status was also collected. Results were analyzed with ordinary least squares regression, controlling for the demographic data. The estimated parameters were significant and indicated an adjusted mean WTP of $93 per month for antihypertensive therapy. The close similarity of the Swedish and U.S. results appears to support the use of WTP as a measure of health state preferences.
References
Nov 1, 1977·Rheumatology and Rehabilitation·P J Scott, E C Huskisson
Dec 1, 1991·Medical Care·A Gafni
Jul 1, 1994·Medical Decision Making : an International Journal of the Society for Medical Decision Making·B O'Brien, J L Viramontes
Nov 1, 1995·Health Economics·C DonaldsonZ Miedzybrodzka
Dec 1, 1995·Journal of General Internal Medicine·T W Odell, M C Gregory
Jan 9, 1991·Health Policy·M Johannesson, B Jönsson
Dec 10, 1990·Journal of Health Economics·M JohannessonL Borgquist
Mar 9, 1993·Journal of Health Economics·M JohannessonU G Gerdtham
Apr 8, 1992·PharmacoEconomics·M JohannessonB Jönsson
Citations
Jun 11, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Nathalie HavetMarie-Odile Carrere
Sep 25, 2003·Journal of Cutaneous Medicine and Surgery·Lauren ParksSteven R Feldman
Dec 2, 2006·Research in Social & Administrative Pharmacy : RSAP·Jamie C Barner, Andrea Branvold
Jul 9, 1999·Clinical Therapeutics·J C BarnerM D Murray
Oct 3, 2000·Health Policy·T H WagnerR J Pasick
Oct 20, 2001·Health Policy·T H WagnerR J Pasick
Oct 28, 1999·Health Policy·T Klose
Sep 1, 1999·Social Science & Medicine·P A Ubel
Apr 12, 2006·International Heart Journal·Hideo YasunagaKazuhiko Ohe
Jan 26, 2007·PharmacoEconomics·Tracey H SachDavid K Whynes
Aug 29, 2009·PharmacoEconomics·Andrej RaschWolfgang Greiner
Sep 15, 2004·Health Policy·Dan GreenbergDavid J Cohen
Aug 8, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Chunyu LiScott D Ramsey
Mar 20, 2008·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Dinesh KhannaJoel Tsevat
Jun 3, 2017·Arthritis Care & Research·Casper WebersAnnelies Boonen
Dec 1, 2003·Expert Review of Pharmacoeconomics & Outcomes Research·Mandy RyanMabelle Amaya-Amaya
Jun 9, 2006·The Journal of Clinical Hypertension·Lawrence R Krakoff
Mar 3, 2007·Community Dentistry and Oral Epidemiology·N OscarsonC Källestål
May 18, 2019·BMC Public Health·Kristoffer Panduro MadsenIngrid Willaing